sulfamethoxypyridazine has been researched along with Bronchiolitis Obliterans in 1 studies
Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.
Bronchiolitis Obliterans: Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godfrey, KM | 1 |
| Wojnarowska, F | 1 |
| Friedland, JS | 1 |
1 other study available for sulfamethoxypyridazine and Bronchiolitis Obliterans
| Article | Year |
|---|---|
Obliterative bronchiolitis and alveolitis associated with sulphamethoxypyridazine (Lederkyn) therapy for linear IgA disease of adults.
Topics: Bronchiolitis Obliterans; Female; Humans; Immunoglobulin A; Middle Aged; Pulmonary Fibrosis; Skin Di | 1990 |